Otsuka acquires Avanir in $3.5 billion deal

02-12-2014

Otsuka acquires Avanir in $3.5 billion deal

JrCasas / Shutterstock.com

Japanese drug maker Otsuka Holdings has agreed to buy Avanir Pharmaceuticals as part of a multi-billion dollar deal that could ease its potential patent woes.


Otsuka, Avanir, patent cliff, M&A

LSIPR